Healthcare News and Headlines

American Healthcare REIT: Trilogy’s MA Strategy, Integrated Nursing Home-AL Campuses Drive Margins
NewsMay 8, 2026

American Healthcare REIT: Trilogy’s MA Strategy, Integrated Nursing Home-AL Campuses Drive Margins

American Healthcare REIT (AHR) highlighted Trilogy Health Services' integrated skilled‑nursing and assisted‑living model, which delivered 14.5% same‑store NOI growth and 91.2% occupancy in Q1. The fee‑free CCRC‑style campuses attracted higher Medicare Advantage rates and strong private‑pay mix, pushing same‑store NOI...

By Skilled Nursing News
FDA Approves Ocrevus for Relapsing-Remitting MS in Children Aged 10 Years and Up
NewsMay 8, 2026

FDA Approves Ocrevus for Relapsing-Remitting MS in Children Aged 10 Years and Up

The U.S. Food and Drug Administration has approved Genentech's ocrelizumab (Ocrevus) for children aged 10 and older who weigh at least 55 lb, expanding its use beyond adult multiple sclerosis (MS) populations. The decision follows the OPERETTA II trial, which demonstrated superior...

By Healio
Development and Validation of a Multimodal Interpretable Machine Learning Model with SHAP for Malignancy Risk Prediction in Bethesda III Thyroid...
NewsMay 8, 2026

Development and Validation of a Multimodal Interpretable Machine Learning Model with SHAP for Malignancy Risk Prediction in Bethesda III Thyroid...

Researchers created a multimodal, interpretable machine‑learning model that combines clinical data, ultrasound features, and BRAF V600E mutation status to predict malignancy in Bethesda III thyroid nodules. In a dual‑center study of 490 patients, the fusion model achieved an AUC of 0.959 in...

By Research Square – News/Updates
Resource Allocation Challenges in Critical Care Nursing: A Cross-Sectional Study of Public Hospitals
NewsMay 8, 2026

Resource Allocation Challenges in Critical Care Nursing: A Cross-Sectional Study of Public Hospitals

A cross‑sectional survey of 200 critical‑care nurses in two Ahmedabad public hospitals identified resource shortages as the dominant operational challenge. Deficiencies in human and material resources represented roughly 27% of the overall challenge burden, while ICU‑related stressors accounted for about...

By Research Square – News/Updates
‘Demographics Are Destiny’ in Palliative Care
NewsMay 8, 2026

‘Demographics Are Destiny’ in Palliative Care

The aging U.S. population is driving a shift toward home‑based palliative care. VITAS Healthcare vice president Jennifer O’Neill warned that workforce growth is lagging behind patient demand and highlighted the need for staff and family education. Industry leaders such as...

By Hospice News
Addressing Manufacturing and Access Barriers in Advanced Therapeutics
NewsMay 8, 2026

Addressing Manufacturing and Access Barriers in Advanced Therapeutics

Advanced cell and gene therapies are moving from research to commercial markets, but their complex manufacturing creates variability that delays patient access. Industry leaders are deploying process analytical technologies (PAT) and artificial intelligence (AI) to gain real‑time insight and predictive...

By BioPharm International
HIV Advocates Ask Regulators In Multiple States To Probe Highmark’s ‘Copay Armor’ Policy
NewsMay 8, 2026

HIV Advocates Ask Regulators In Multiple States To Probe Highmark’s ‘Copay Armor’ Policy

The HIV+HEP Policy Institute has asked insurance regulators in Delaware, Pennsylvania and West Virginia to investigate Highmark Blue Cross Blue Shield’s 2026 exchange plans. The group alleges the plans use a “Copay Armor” or copay‑maximizer program that raises out‑of‑pocket costs...

By Inside Health Policy
Cigna Getting Out of Individual ACA Market
NewsMay 8, 2026

Cigna Getting Out of Individual ACA Market

Cigna announced it will wind down its individual ACA exchange business by the end of 2026, citing a shrinking customer base and a need to concentrate on core growth platforms. The insurer’s enrollment fell to 355,000 this quarter, down from...

By Healthcare Innovation
Mixed-Methods Evaluation of a Multi-Level, Multi-Component Implementation Theory: Results From Scaling Up Obstetric Triage in Six Referral Hospitals in Ghana
NewsMay 8, 2026

Mixed-Methods Evaluation of a Multi-Level, Multi-Component Implementation Theory: Results From Scaling Up Obstetric Triage in Six Referral Hospitals in Ghana

A midwife‑led obstetric triage system (OTIP) was scaled across six Ghanaian referral hospitals. Within 12 months, women assessed within 10 minutes rose from 5% to 85%, with 96% adoption of color‑coded wristbands and 83% accurate risk classification. Implementation outcomes showed...

By Research Square – News/Updates
Economic Assistance and Incentives for Drug Development
NewsMay 8, 2026

Economic Assistance and Incentives for Drug Development

The FDA and other federal agencies offer a suite of pre‑approval assistance and post‑approval incentives to lower the financial risk of drug development. Programs such as the Orphan Products Grant, SBIR/STTR funding, and PDUFA fee waivers help sponsors fund clinical...

By FDA
6 Signs It's Time to Talk to a Mental Health Professional
NewsMay 8, 2026

6 Signs It's Time to Talk to a Mental Health Professional

Living with diabetes can trigger emotional strain that goes beyond blood‑sugar control, manifesting as diabetes distress, burnout, or depression. The CDC reports that 24% of adults with diabetes experience moderate distress and 7% severe, which correlates with poorer self‑management and...

By Verywell Mind
Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
NewsMay 8, 2026

Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs

Odyssey Therapeutics priced 15.5 million shares at $18, raising $304 million including a $25.2 million private placement. The funds will finance Phase 2a/2b trials of OD‑001, an oral RIPK2 inhibitor for ulcerative colitis, and advance OD‑002, a SLC15A4 inhibitor, toward Phase 1/2a. Odyssey’s platform targets...

By MedCity News
How to Manage a Virtualization Migration in Healthcare
NewsMay 8, 2026

How to Manage a Virtualization Migration in Healthcare

Healthcare providers are accelerating migrations to new virtualization platforms as rising license fees and bundled pricing strain budgets. Executives like Nutanix’s Scott Ragsdale warn that a migration touches a decade of operational procedures, technical debt, and clinical workloads. Successful moves...

By HealthTech Magazine
Precision Neuroscience CEO on Medtronic Partnership, What's Next
NewsMay 8, 2026

Precision Neuroscience CEO on Medtronic Partnership, What's Next

Precision Neuroscience CEO Michael Mager announced a partnership with Medtronic to commercialize a reversible brain‑computer interface (BCI) that lets paralyzed users control digital devices with thought. The company has temporarily implanted 83 devices in volunteers under FDA clearance and is...

By Bloomberg – Markets
Where Addus, BrightSpring, Pennant See Upside In Fraud Crackdowns, Opportunity In M&A
NewsMay 8, 2026

Where Addus, BrightSpring, Pennant See Upside In Fraud Crackdowns, Opportunity In M&A

Q1 2026 earnings reveal that home‑based care leaders are navigating two converging forces: a federal crackdown on fraud, waste and abuse, and a surge in M&A activity. BrightSpring and Pennant are still digesting their 2025 Amedisys acquisitions while scouting disciplined...

By Home Health Care News
Three in 10 AVRs in Adults Younger Than 65 Are Transcatheter
NewsMay 8, 2026

Three in 10 AVRs in Adults Younger Than 65 Are Transcatheter

A registry analysis of 34,504 U.S. patients under 65 undergoing aortic valve replacement shows 28.5% received TAVI, up from 15.7% in 2016 and plateauing around 29% by 2024, while isolated SAVR fell from 43.8% to 27.0%. Growth in TAVI accelerated...

By TCTMD
Exclusive-Kennedy's Health Officials Explored US Ban of some Widely Used Antidepressants, Sources Say
NewsMay 8, 2026

Exclusive-Kennedy's Health Officials Explored US Ban of some Widely Used Antidepressants, Sources Say

U.S. Health and Human Services officials recently examined whether to restrict certain selective serotonin reuptake inhibitors (SSRIs) such as Zoloft, Prozac and Lexapro, amid Health Secretary Robert F. Kennedy Jr.'s push to curb their use. Kennedy announced reimbursement guidelines for...

By Yahoo Finance – Finance News
HIMSSCast: ‘Implement an AI Solution in Digestible Chunks’
NewsMay 8, 2026

HIMSSCast: ‘Implement an AI Solution in Digestible Chunks’

Northwell Health Labs has integrated artificial intelligence into its revenue cycle management, achieving a 40% reduction in error rates. The AI was deployed in small, digestible chunks, allowing the system to generate quick wins and avoid the pitfalls of a...

By Healthcare Finance News (HIMSS Media)
Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs
NewsMay 8, 2026

Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs

Entera Bio reported Q1 2026 results, highlighting a streamlined Phase 3 protocol for its lead osteoporosis candidate EB613 and a completed Phase 1 bridging study that positions a single‑tablet formulation for the upcoming trial. The company also advanced its partnership with OPKO, securing...

By GlobeNewswire – Earnings Releases
Glaucoma, Hypertension May Be Linked to Dementia Risk
NewsMay 8, 2026

Glaucoma, Hypertension May Be Linked to Dementia Risk

Researchers presented data linking glaucoma and hypertension to poorer cognitive performance, as measured by the Montreal Cognitive Assessment. The analysis used an AI‑ready electronic health record dataset to compare patients with and without glaucoma. Both conditions were more prevalent among...

By Healio
COVID Response Coordinator Shares Why the Hantavirus Won’t Turn Into Another Pandemic
NewsMay 8, 2026

COVID Response Coordinator Shares Why the Hantavirus Won’t Turn Into Another Pandemic

Former White House COVID‑19 response coordinator Dr. Ashish Jha told Good Morning America that the recent hantavirus outbreak on the Dutch cruise ship MV Hondius is unlikely to become a pandemic. He explained that hantavirus, especially the rare Andes strain,...

By Men’s Journal
Bristol Myers Squibb Accused of Buying Off Competitors to Delay Development of Generic Cancer Drugs
NewsMay 8, 2026

Bristol Myers Squibb Accused of Buying Off Competitors to Delay Development of Generic Cancer Drugs

Centene Corp. filed a federal antitrust lawsuit accusing Bristol Myers Squibb (BMS) of conspiring with generic manufacturers to delay competition for lenalidomide and its brand version Revlimid. The complaint says BMS earned $5.2 billion in Revlimid sales in 2023 and raised...

By Courthouse News Service
Google Unveils Screenless Fitbit Air, New Google Health App
NewsMay 8, 2026

Google Unveils Screenless Fitbit Air, New Google Health App

Google introduced the screenless Fitbit Air, a $99.99 wearable that tracks heart rate, sleep, oxygen, temperature and activity without a display. The device pairs with the rebranded Google Health app—formerly the Fitbit app—offering a unified dashboard that aggregates data from...

By MobiHealthNews (HIMSS Media)
Proportion of Women Undergoing TAVI for Aortic Stenosis Declining in US
NewsMay 8, 2026

Proportion of Women Undergoing TAVI for Aortic Stenosis Declining in US

A decade‑long Medicare analysis shows the share of women undergoing transcatheter aortic valve implantation (TAVI) fell from 47.6% in 2013 to 43.6% in 2022, even as total procedure volumes surged. Women experienced higher periprocedural mortality (2.5% vs 2.2%), more vascular...

By TCTMD
[World Report] “We Don’t Want It to Happen to Others”: Suicide in Young Māori
NewsMay 8, 2026

[World Report] “We Don’t Want It to Happen to Others”: Suicide in Young Māori

Suicide remains the leading cause of death for New Zealanders aged 15‑19, with Māori youth disproportionately affected. Recent research highlights a stark gap between Māori and non‑Māori suicide rates, underscoring systemic inequities. Advocates and community leaders are urging a shift toward...

By The Lancet (Current)
[Comment] Could Enpatoran Add to Our Therapeutic Toolbox in SLE?
NewsMay 8, 2026

[Comment] Could Enpatoran Add to Our Therapeutic Toolbox in SLE?

Systemic lupus erythematosus (SLE) remains a heterogeneous disease with only two novel agents—BAFF and type‑1 interferon receptor inhibitors—approved since the 1950s. These drugs often fall short as stand‑alone treatments, are expensive, and are not uniformly accessible worldwide. Clinicians continue to...

By The Lancet (Current)
[Comment] RTS,S/AS01 Implementation Reduces Mortality in African Children
NewsMay 8, 2026

[Comment] RTS,S/AS01 Implementation Reduces Mortality in African Children

A recent Lancet analysis shows that the RTS,S/AS01 (Mosquirix) malaria vaccine rollout in Ghana, Kenya and Malawi cut child mortality by roughly 20% after three years of implementation. The program reached over five million children under five, integrating the vaccine...

By The Lancet (Current)
Grandstanding In Congressional Hearings Doesn’t Solve Healthcare Problems
NewsMay 8, 2026

Grandstanding In Congressional Hearings Doesn’t Solve Healthcare Problems

Congressional health‑care hearings have become arenas for partisan grandstanding, with lawmakers berating CEOs, insurers and the Affordable Care Act rather than crafting solutions. Despite occasional bipartisan agreement on hospital cost inflation and prior‑authorization hurdles, the sessions rarely move beyond political...

By Forbes – Healthcare
HIMSS SoCal Chapter's CXO Summit
NewsMay 8, 2026

HIMSS SoCal Chapter's CXO Summit

The Healthcare Information and Management Systems Society (HIMSS) Southern California Chapter will host its CXO Summit on May 12 at the Richard Nixon Library in Yorba Linda. President Mary Beth Seaman highlighted the event’s agenda, which centers on reshaping population health through...

By MobiHealthNews (HIMSS Media)
Effect of Subscapularis Integrity on Functional Recovery After Posterior Latissimus Dorsi Tendon Transfer for Posterior–Superior Irreparable Rotator Cuff Tears
NewsMay 8, 2026

Effect of Subscapularis Integrity on Functional Recovery After Posterior Latissimus Dorsi Tendon Transfer for Posterior–Superior Irreparable Rotator Cuff Tears

Posterior latissimus dorsi (LD) tendon transfer significantly reduces pain and improves function in patients with posterior‑superior irreparable rotator cuff tears (PSIRCTs). In a retrospective series of 53 patients, those with an intact subscapularis tendon achieved higher Constant (70.7 vs 62.3)...

By Research Square – News/Updates
CXO Summit Lets Healthcare Leaders Share Ideas
NewsMay 8, 2026

CXO Summit Lets Healthcare Leaders Share Ideas

The HIMSS Southern California Chapter will host a CXO Summit aimed at fostering candid dialogue among health‑care executives. The event targets chief information, finance, and operations officers who must navigate rapid policy shifts and modernize care delivery. Sessions will explore...

By Healthcare Finance News (HIMSS Media)
Makary Critics Rejoice As Trump Reportedly Weighs Firing FDA Chief
NewsMay 8, 2026

Makary Critics Rejoice As Trump Reportedly Weighs Firing FDA Chief

President Donald Trump is reportedly weighing the dismissal of FDA Commissioner Marty Makary, whose tenure has been marked by aggressive drug‑pricing reforms and high‑profile clashes with the pharmaceutical industry. Makary, appointed as an ally of HHS Secretary Robert F. Kennedy...

By Inside Health Policy
Electrospinning of Hydroxypropyl Chitosan Nanofibers for Bone Regeneration Application
NewsMay 8, 2026

Electrospinning of Hydroxypropyl Chitosan Nanofibers for Bone Regeneration Application

Researchers electrospun nanofiber mats using hydroxypropyl chitosan (HPCH) and poly(vinyl alcohol) (PVA) in varying ratios to assess osteoconductive potential in MC3T3 pre‑osteoblast cells. Characterization by SEM, FT‑IR and mechanical testing confirmed uniform fiber formation. Biological assays showed that a 50/50...

By Research Square – News/Updates
FDA Issues Most Serious Recall for Certain Pacemaker Devices by Boston Scientific
NewsMay 8, 2026

FDA Issues Most Serious Recall for Certain Pacemaker Devices by Boston Scientific

The FDA issued a Class I recall for Boston Scientific’s ACCOLADE pacemakers and cardiac resynchronization therapy models after detecting a software‑related battery flaw that can trigger Safety Mode and limit pacing. The agency advises clinicians to install a software upgrade during...

By AHA News – American Hospital Association
Glint of Light in Therapy for Deadly ALS After Decades of Struggle
NewsMay 8, 2026

Glint of Light in Therapy for Deadly ALS After Decades of Struggle

Researchers reported that tofersen, an antisense oligonucleotide targeting the SOD1 gene, dramatically slowed and even reversed disease progression in a subset of ALS patients with the rare SOD1 mutation. The phase‑III trial, published in JAMA Neurology, showed about a quarter...

By Harvard Gazette – Science & Health/Mind Brain Behavior
Could Viagra and Cialis Help Protect Eye Health? New Study Suggests a Link
NewsMay 8, 2026

Could Viagra and Cialis Help Protect Eye Health? New Study Suggests a Link

A new observational study of more than 47,000 men aged 40 and older found that users of phosphodiesterase‑5 (PDE‑5) inhibitors such as Viagra, Cialis and Levitra had a modestly lower incidence of glaucoma signs and open‑angle glaucoma over three years....

By Men’s Journal
Researchers Debunk ‘5-Second Rule’ in Operating Room
NewsMay 8, 2026

Researchers Debunk ‘5-Second Rule’ in Operating Room

Researchers at Duke University Medical Center dropped 213 polyethylene knee and hip liners onto operating‑room floors and found that 34% became contaminated with clinically important pathogens within seconds. Disinfection with 2% chlorhexidine‑alcohol or 10% povidone‑iodine reduced overall contamination to 19%,...

By Healio
There Are Ants in This Canadian Hospital. Again.
NewsMay 8, 2026

There Are Ants in This Canadian Hospital. Again.

Ants have forced Carman Memorial Hospital in Manitoba to suspend surgeries indefinitely after an infestation was discovered in the operating room. Sixteen elective procedures were postponed, marking the third ant-related disruption since August 2024. Southern Health‑Santé Sud is working with exterminators...

By New York Times – Science
Inclisiran Linked to Lower MACE, AMI Rates in High-Risk ASCVD Population
NewsMay 8, 2026

Inclisiran Linked to Lower MACE, AMI Rates in High-Risk ASCVD Population

Inclisiran, added to maximally tolerated statins, lowered 4‑point major adverse cardiovascular events (MACE) from 22.7% to 14.6% in a real‑world ASCVD cohort. The therapy also reduced acute myocardial infarction (5.0% vs 8.5%) and all‑cause hospitalizations (20.8% vs 28.8%) over one...

By AJMC (The American Journal of Managed Care)
How to Manage Your Health Anxiety About Hantavirus
NewsMay 8, 2026

How to Manage Your Health Anxiety About Hantavirus

An outbreak of hantavirus on the Dutch cruise ship MV Hondius has sickened eight passengers, killing three. WHO officials stress it is not COVID, but the news has sparked widespread health anxiety reminiscent of early 2020. Experts explain that post‑COVID...

By TIME
Trump Reportedly Plans to Fire FDA Commissioner Makary
NewsMay 8, 2026

Trump Reportedly Plans to Fire FDA Commissioner Makary

President Donald Trump has reportedly approved a plan to dismiss FDA Commissioner Marty Makary, who has served just over a year. Makary’s tenure featured initiatives to speed drug reviews, curb deceptive advertising, and push food manufacturers to eliminate synthetic dyes....

By STAT News — Pharma
Taking a Look at the Toxicity Trade-Offs of EPCORE FL-1
NewsMay 8, 2026

Taking a Look at the Toxicity Trade-Offs of EPCORE FL-1

The phase 3 EPCORE FL‑1 trial added AbbVie/Genmab’s bispecific antibody epcoritamab to the rituximab‑lenalidomide (R²) regimen for relapsed or refractory follicular lymphoma. The triplet produced a 79% reduction in progression‑or‑death risk and lifted 16‑month progression‑free survival to 85.5%, nearly doubling the complete...

By AJMC (The American Journal of Managed Care)
Search for Regulatory References | Drugs
NewsMay 8, 2026

Search for Regulatory References | Drugs

The FDA has compiled a searchable reference guide that aggregates key regulatory resources for drug and biologics developers. It includes links to guidance on the BPCI Act’s license provision, Abbreviated New Drug Applications (ANDA), CDER small‑business assistance, and submission address...

By FDA
The Healthcare Careers Being Shaped Most Directly by AI and Digital Transformation
NewsMay 8, 2026

The Healthcare Careers Being Shaped Most Directly by AI and Digital Transformation

AI and digital transformation are redefining core healthcare professions, moving health information management, health informatics, and nursing from traditional, paper‑based or siloed functions to data‑centric, AI‑enabled roles. Health information managers now oversee data governance, interoperability standards, and AI‑ready datasets, while...

By HealthWorks Collective – Technology
STAT+: Capricor Therapeutics Accuses Nippon Shinyaku of Slow-Walking Plans on Duchenne Drug
NewsMay 8, 2026

STAT+: Capricor Therapeutics Accuses Nippon Shinyaku of Slow-Walking Plans on Duchenne Drug

Capricor Therapeutics has filed a lawsuit in New Jersey alleging that Nippon Shinyaku and its U.S. arm, NS Pharma, are deliberately stalling the U.S. launch of deramiocel, its experimental Duchenne muscular dystrophy therapy. The complaint highlights a pricing formula error...

By STAT News — Pharma
AATS Helps Heart Surgeons Diagnose and Manage Heparin-Induced Thrombocytopenia
NewsMay 8, 2026

AATS Helps Heart Surgeons Diagnose and Manage Heparin-Induced Thrombocytopenia

A new expert consensus from the American Association for Thoracic Surgery (AATS) tackles the persistent challenges of diagnosing and managing heparin‑induced thrombocytopenia (HIT) in cardiac‑surgery patients. The 17‑member panel recommends delaying antibody testing until a biphasic platelet‑count pattern emerges, reducing...

By Cardiovascular Business
FDA Grants Seventh Approval Under the National Priority Voucher Pilot Program
NewsMay 8, 2026

FDA Grants Seventh Approval Under the National Priority Voucher Pilot Program

The FDA approved Bizengri (zenocutuzumab‑zbco) for adults with advanced, unresectable or metastatic cholangiocarcinoma harboring NRG1 gene fusions, marking the seventh clearance under the Commissioner’s National Priority Voucher (CNPV) pilot. The approval follows a single‑arm trial of 19 patients that showed...

By FDA
AI & Data Exchange 2026: NIH’s Susan Gregurick on Overcoming Data Silos with AI Analytics
NewsMay 8, 2026

AI & Data Exchange 2026: NIH’s Susan Gregurick on Overcoming Data Silos with AI Analytics

At the AI & Data Exchange 2026, NIH associate director for data science Susan Gregurick outlined the agency’s aggressive push to use artificial intelligence for breaking data silos and accelerating health research. NIH is leveraging AI partnerships with the Energy Department...

By Federal News Network
Mixed Results for Targeted Focal Cooling During Stroke Thrombectomy
NewsMay 8, 2026

Mixed Results for Targeted Focal Cooling During Stroke Thrombectomy

Two Chinese phase‑III trials presented at ESOC 2026 yielded opposing conclusions on intra‑arterial hypothermia during endovascular thrombectomy for acute ischemic stroke. CHILL‑ART reported a 54.7% functional‑independence rate versus 39.8% with sham, translating to a number‑needed‑to‑treat of seven, and a modest reduction...

By TCTMD